AI Could Save Trillions in U.S. Healthcare Costs. These Companies Are Leading the Way.

Early detection, I believe, is one of the smartest investments you can make, whether we’re talking about your portfolio or your health.

That’s why I recently made the decision to get a full-body MRI scan from Prenuvo and a multi-cancer blood test called Galleri, available from GRAIL.

The experience was eye-opening. In under an hour, the Prenuvo scan assessed my entire body using AI-enhanced imaging. No radiation or needles were necessary. The Galleri test, meanwhile, screens for a molecular “fingerprint” shed by cancer cells into the bloodstream before any symptoms appear.

Together, these two tests represent a new frontier in preventive medicine, one that could detect dozens of cancers years before they’d show up through conventional means.

I was so impressed by the experience that I mentioned both tests during my presentation this week at the Weiss Investment Summit in Boca Raton. Afterward, I was flooded with questions, and not just about the health implications but about the investment opportunities behind the technology.

Read more: AI: The Good, the Bad and the Ugly